Repurposing of lonafarnib as a treatment for SARS-CoV-2 infection.
Khan M, Irvin P, Park SB, Ivester HM, Ricardo-Lax I, Leek M, Grieshaber A, Jang ES, Coutermarsh-Ott SL, Zhang Q, Maio N, Jiang JK, Li B, Huang W, Wang AQ, Xu X, Hu Z, Zheng W, Ye Y, Rouault T, Rice CM, Allen IC, Liang TJ.
Khan M, et al. Among authors: park sb.
JCI Insight. 2024 Dec 3:e182704. doi: 10.1172/jci.insight.182704. Online ahead of print.
JCI Insight. 2024.
PMID: 39625789
Free article.